KMT2A and acute myeloid leukemia: As the innate epigenetic status could affect OSKM targets, ultimately resulting in different cell fates between normal cKit+ HSPCs and MLL-AF9 AML cells, future studies should focus on the role of pre-existing chromatin status in promoting this selective eradication effect.